Protocols
1 protocol(s) meet the specified criteria
Drug: Enfortumab Vedotin
Protocol No.TitleStatus
SGN22E-002A phase 1b dose-escalation and dose-expansion study of enfortumab vedotin (ASG-22CE) in combination with immune checkpoint inhibitor (CPI) therapy for treatment of patients with locally advanced or metastatic urothelial cancerOpen